Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Leiomyosarcoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Radiotherapy 6Radiation 3Panobinostat 3Cyclophosphamide 3ribociclib 2Temozolomide 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Everolimus 2Etoposide 2Dasatinib 2vandetanib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1marizomib 1irinotecan sucrosofate 1gallium maltolate 1etoposide phosphate 1crenolanib 1balstilimab 1adavosertib 1abemaciclib 1X-Rays 1Vorinostat 1Vaccines 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diffuse Intrinsic Pontine Glioma × PTC596 × Clear all
NCT03605550 2026-03-27

A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma

Nationwide Children's Hospital

Phase 1 Active not recruiting
64 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡